about
Role of stacking interactions in the binding sequence preferences of DNA bis-intercalators: insight from thermodynamic integration free energy simulations.Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cellsCytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapyConformational Preferences of π-π Stacking Between Ligand and Protein, Analysis Derived from Crystal Structure Data Geometric Preference of π-π Interaction.Dihydroimidazophenanthridinium (DIP)-based DNA binding agents with tuneable structures and biological activity.Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders.Allosteric DNA nanoswitches for controlled release of a molecular cargo triggered by biological inputs.DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular ConsequencesMorindone, an anthraquinone, intercalates DNA sans toxicity: a spectroscopic and molecular modeling perspective.Ethyl 1,6-dimethyl-2-oxo-4-(quinolin-4-yl)-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) LigandScreening of threading bis-intercalators binding to duplex DNA by electrospray ionization tandem mass spectrometry.Polycyclic aromatic compounds as anticancer agents: Evaluation of synthesis and in vitro cytotoxicityIntercalation-mediated nucleic acid nanoparticles for siRNA delivery.Effects of anticancer drugs on transcription factor-DNA interactions.Regioselective copper-catalyzed amination of bromobenzoic acids using aliphatic and aromatic amines.Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivativesSynthesis and Cytotoxicity Study of New Cyclopenta [b] quinoline-1,8-dione Derivatives.Molecular dynamics simulations and coupled nucleotide substitution experiments indicate the nature of A{middle dot}A base pairing and a putative structure of the coralyne-induced homo-adenine duplex.A Systems Biology Approach to Understanding the Mechanisms of Action of an Alternative Anticancer Compound in Comparison to Cisplatin.Electrolytes in biomolecular systems studied with the 3D-RISM/RISM theory.DNA Interaction Studies of Selected Polyamine Conjugates.A new method for the determination of the relative affinity of a ligand against various DNA sequences by electrospray ionization mass spectrometry. Application to a polyamide minor groove binder.Synthesis, Biological Activity and Preliminary in Silico ADMET Screening of Polyamine Conjugates with Bicyclic Systems.Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates.A review on acridinylthioureas and its derivatives: biological and cytotoxic activity.pH sensitive coiled coils: a strategy for enhanced liposomal drug delivery.A unique perylene-based DNA intercalator: localization in cell nuclei and inhibition of cancer cells and tumors.Synthesis of β-carboline-benzimidazole conjugates using lanthanum nitrate as a catalyst and their biological evaluation.Synthesis and antiproliferative activity evaluation of imidazole-based indeno[1,2-b]quinoline-9,11-dione derivatives.Synthesis and biological evaluation of new bischromone derivatives with antiproliferative activity.Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells.Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity.Noncovalent interactions in extended systems described by the effective fragment potential method: theory and application to nucleobase oligomers.Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of methoxy dibenzofluorene derivatives.4-[(1,3-Dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-2-yl)meth-yl]-N'-[(E)-4-nitro-benzyl-idene]benzene-sulfono-hydrazide dimethyl sulfoxide monosolvate.Design, synthesis and DNA interaction study of new potential DNA bis-intercalators based on glucuronic acid.Diastereomeric bactericidal effect of Ru(phenanthroline)2 dipyridophenazine.5-Butyl-amino-2-[2-(dimethyl-amino)eth-yl]-1H-benz[de]isoquinoline-1,3(2H)-dione.
P2860
Q24817026-E2B97CC1-A028-4635-8090-BF7AF7AF3C98Q28469266-14094D3C-F7B2-4A87-9A17-4D3EB5DD3DA9Q30390185-F9BEA005-62F5-4107-84BB-9FC0FE6B59ADQ30993557-6F571AD5-472A-4434-AF64-150956248B5AQ33259956-B364BD76-8A4C-4A5F-A978-48172016D536Q33685192-CD4CF594-173D-4290-BDA9-1FF7F1AE2D08Q33749685-42625178-F10D-4D5F-BE53-8AB70CFBA652Q34042848-01B02183-3CCD-4C43-BE0D-BE607581CB59Q34283968-101EA739-8628-49A7-99D7-B74EC971E177Q34428294-19E42866-5B3D-4C34-AC36-D6FA67AE0C91Q35652998-84BD7011-FDD6-4352-A3D8-557EF1C25BC4Q35754397-4796B8AB-CB95-45CF-9DD6-61E9A5BB045BQ35995460-73102A7D-F504-419F-A7B0-860C17AD342EQ36155481-63582D4B-D3F5-4449-B1AF-D90535BCD97AQ36158697-BB0F3636-36CB-4B30-BDD6-90DB2CD7E166Q36866009-73CC3A08-34DF-48C9-BB90-79DAB0E2E9A5Q36871484-0D818FC5-0695-4A41-99E5-2AB5903A065FQ37268079-5DE6D2FE-417B-43AC-ADBF-3FA66A6553DCQ37477496-2120FDCD-E2D4-4495-BB3E-0A0BA3B60687Q37636367-28BE6F10-0435-4FDA-A069-CBC78ED2A635Q37969661-093E2599-8615-476F-9788-51EBD1F7164DQ38290849-1E6A6F8B-CAEE-4CA0-A58D-8785A390CF8FQ38354542-76D2F9D3-5494-41F8-990B-A57E20BDEFB0Q38703748-E83120A6-C448-4EA2-B1DA-409978FF10E5Q38735626-3AECCAB8-B9F7-4630-AF0F-0E117F0D10D5Q38736001-04DC7970-798A-4908-A6A2-05612A7C38FAQ38794157-3424113D-DCBD-45A8-A60D-BCB793FFB640Q38979797-899DE5DA-3ADF-4544-BBAC-833426068272Q39017798-D759BBBC-4F7D-44DC-B011-65B61BC7965AQ39188701-9A29E114-E3B3-4DF5-A596-129D44FAEA42Q39251773-327F39D5-12A4-40D8-A5A1-603E31CCC636Q39465921-8CD18A80-6EE1-483C-86D5-88C1EA071834Q39752703-DD5AE0AE-CAFA-428E-A6DC-E32E28BE1542Q39993736-5D8B0A6E-8F45-443C-9C9E-6B89A29D8B0EQ41219653-3E5FE29F-6440-44B2-B097-83947EFBE372Q41856170-00A33A8B-73A7-469B-AD4D-FE9E0EE3B1FCQ41861962-08DA6362-4ED2-4A05-9BA7-AFC4DBF2F176Q41937604-9B1A371D-BD89-4020-8B69-711A4EA104C5Q42114261-17EDA1D3-0638-4699-83FF-A80A9229599EQ42367606-8DF17F20-44D9-421C-9BDF-2A067F182B72
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intercalators as anticancer drugs.
@ast
Intercalators as anticancer drugs.
@en
type
label
Intercalators as anticancer drugs.
@ast
Intercalators as anticancer drugs.
@en
prefLabel
Intercalators as anticancer drugs.
@ast
Intercalators as anticancer drugs.
@en
P2093
P356
P1476
Intercalators as anticancer drugs
@en
P2093
P304
P356
10.2174/1381612013397113
P577
2001-11-01T00:00:00Z